Cryptic Epitopes Induce High-Titer Humoral Immune Response in Patients with Cancer

In search of novel markers for diagnosis, prognosis, and therapy of cancer, screening of rcDNA expression libraries with patient’s sera has been established as a valuable tool for identification of cancer-specific Ags. Interestingly, besides the expected humoral responses to annotated proteins, patients with cancer were frequently found to have serum Abs that bind to peptides without homology to known proteins. So far, the nature of these unconventional epitopes and their possible significance in tumor immunology have never been thoroughly investigated. In our study, we specifically analyzed humoral immune response toward such peptides in patients with pancreatic or breast cancer using yeast-displayed cDNA expression libraries derived from tumor tissue. A detailed analysis of the identified peptides revealed that they originated from translation of sequences outside annotated open reading frames and may derive from the use of alternative start codons or from DNA indel mutations. In several cases, the corresponding mRNA templates have a known association with cancer. In a final analysis, we were able to detect one of these tumor Ags in cancer tissue arrays by a selected Fab-Ab. We conclude that cryptic epitopes may elicit specific humoral immune responses in patients with cancer and thus play a role in immunologic surveillance. Due to the high prevalence of immune responses against some of the peptides, they may also be valuable markers for cancer diagnosis, prognosis, or therapy monitoring.

[1]  Laura Smith.  Post-transcriptional regulation of gene expression by alternative 5'-untranslated regions in carcinogenesis. , 2008, Biochemical Society transactions.

[2]  J. Delrow,et al.  Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation , 2008, The EMBO journal.

[3]  Y. Yen,et al.  Autoantibodies as potential biomarkers for breast cancer , 2008, Breast Cancer Research.

[4]  Lixin Sun,et al.  Profiling Tumor-Associated Autoantibodies for the Detection of Colon Cancer , 2008, Clinical Cancer Research.

[5]  M. Chatterjee,et al.  Non-traditional immunogens and their application to immunotherapy. , 2008, Current opinion in molecular therapeutics.

[6]  Sumio Sugano,et al.  Diversity of Translation Start Sites May Define Increased Complexity of the Human Short ORFeome*S , 2007, Molecular & Cellular Proteomics.

[7]  W. Green,et al.  Alternative Translational Products and Cryptic T Cell Epitopes: Expecting the Unexpected , 2006, The Journal of Immunology.

[8]  S. Fuqua,et al.  Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. , 2006, Molecular endocrinology.

[9]  J. Yewdell,et al.  The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.

[10]  M. Pfreundschuh,et al.  Serological immune response to cancer testis antigens in patients with pancreatic cancer , 2006, International journal of cancer.

[11]  T. Hughes,et al.  Regulation of gene expression by alternative untranslated regions. , 2006, Trends in genetics : TIG.

[12]  M. Pfreundschuh,et al.  Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer , 2006, International journal of cancer.

[13]  Guillaume J. Filion,et al.  A Family of Human Zinc Finger Proteins That Bind Methylated DNA and Repress Transcription , 2006, Molecular and Cellular Biology.

[14]  M. Pfreundschuh,et al.  Serological identification of breast cancer‐related antigens from a Saccharomyces cerevisiae surface display library , 2005, International journal of cancer.

[15]  Debashis Ghosh,et al.  Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.

[16]  C. Mcmahan,et al.  Erratum to “Tumor immunotherapy with alternative reading frame peptide antigens” [Immunobiology 209 (2004) 535–544] , 2005 .

[17]  E. Celis,et al.  Recognition of Prostate and Breast Tumor Cells by Helper T Lymphocytes Specific for a Prostate and Breast Tumor-Associated Antigen, TARP , 2005, Clinical Cancer Research.

[18]  Antonio Bertoletti,et al.  Translation from Cryptic Reading Frames of DNA Vaccines Generates an Extended Repertoire of Immunogenic, MHC Class I-Restricted Epitopes1 , 2005, The Journal of Immunology.

[19]  E. Gold,et al.  Epidemiology of pancreatic cancer , 1984, World Journal of Surgery.

[20]  C. Mcmahan,et al.  Tumor immunotherapy with alternative reading frame peptide antigens. , 2004, Immunobiology.

[21]  M. Pfreundschuh,et al.  Dissecting cytotoxic T cell responses towards the NY‐ESO‐1 protein by peptide/MHC‐specific antibody fragments , 2004, European journal of immunology.

[22]  Seung-Yong Jeong,et al.  Prognostic significance of microsatellite instability in sporadic colorectal cancer , 2004, International Journal of Colorectal Disease.

[23]  E. Smeland,et al.  NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer , 2004, The Prostate.

[24]  S. Rosenberg,et al.  T Cells Associated with Tumor Regression Recognize Frameshifted Products of the CDKN2A Tumor Suppressor Gene Locus and a Mutated HLA Class I Gene Product , 2004, The Journal of Immunology.

[25]  J. Neoptolemos,et al.  Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer , 2004, Clinical Cancer Research.

[26]  I. Pastan,et al.  Human CTLs to Wild-Type and Enhanced Epitopes of a Novel Prostate and Breast Tumor-Associated Protein, TARP, Lyse Human Breast Cancer Cells , 2004, Cancer Research.

[27]  J. Gebert,et al.  Identification of an HLA-A0201-Restricted CTL Epitope Generated by a Tumor-Specific Frameshift Mutation in a Coding Microsatellite of the OGT Gene , 2003, Journal of Clinical Immunology.

[28]  T. Boon,et al.  T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis , 2004, Immunogenetics.

[29]  M. Ueda,et al.  Yeast cell-surface display—applications of molecular display , 2004, Applied Microbiology and Biotechnology.

[30]  Franco Felici,et al.  Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients , 2003, International journal of cancer.

[31]  S. Okabe,et al.  Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. , 2003, Cancer research.

[32]  M. Griffioen,et al.  CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame , 2003, The Journal of Immunology.

[33]  A. Stromberg,et al.  Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. , 2003, Cancer detection and prevention.

[34]  Gerd Ritter,et al.  Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. , 2003, Cancer immunity.

[35]  S. Rosenberg,et al.  Identification of BING-4 Cancer Antigen Translated From an Alternative Open Reading Frame of a Gene in the Extended MHC Class II Region Using Lymphocytes From a Patient With a Durable Complete Regression Following Immunotherapy , 2002, The Journal of Immunology.

[36]  S M Hanash,et al.  An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Yewdell,et al.  At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. , 2001, Journal of cell science.

[38]  V. Jongeneel.  Towards a cancer immunome database. , 2001, Cancer immunity.

[39]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[40]  K D Wittrup,et al.  Yeast surface display for directed evolution of protein expression, affinity, and stability. , 2000, Methods in enzymology.

[41]  F. Triebel,et al.  A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. , 1999, Journal of immunology.

[42]  Z. Marschall,et al.  Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines , 1998, Gut.

[43]  Yao-Tseng Chen,et al.  Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Lloyd J. Old,et al.  A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.

[45]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[46]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[47]  A. Cattaneo,et al.  An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. , 1997, Gene.

[48]  Yao-Tseng Chen,et al.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Yewdell,et al.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.

[50]  S. Rosenberg,et al.  Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen , 1996, The Journal of experimental medicine.

[51]  M. Pfreundschuh,et al.  Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Clackson,et al.  Making antibody fragments using phage display libraries , 1991, Nature.